Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Medigus Surges Most Since 2009 on FDA Approval Request

Jan. 25 (Bloomberg) -- Medigus Ltd. surged the most since August 2009 after the company said it will seek U.S. Food and Drug Administration approval to market its SRS device for the treatment of gastro-esophageal reflux disease.

The shares of the devloper of endoscopic procedures and devices rose 22 percent, the most since Aug. 3, 2009, to 0.734 shekel at the 4:30 p.m. close in Tel Aviv.

To contact the reporter on this story: Shoshanna Solomon in Tel Aviv at ssolomon22@bloomberg.net

To contact the editor responsible for this story: Claudia Maedler at cmaedler@bloomberg.net

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.